Effects and Cost-Effectiveness of Pharmacogenetic Screening Among Elderly Starters With Antidepressants: A Pragmatic Randomized Controlled Trial
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Nortriptyline (Primary) ; Venlafaxine (Primary)
- Indications Major depressive disorder
- Focus Pharmacogenomic; Pharmacokinetics
- Acronyms CYSCE
- 18 Aug 2017 Biomarkers information updated
- 07 Feb 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Feb 2013 New trial record